跳到正文
原文
Nature 健康护理主题·· 22 天前AI 评分41

患者报告结局在分子肿瘤委员会指导诊疗中的前景与局限:迈向以患者为中心的精准肿瘤学框架

The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology

AI 导读

患者报告结局在分子肿瘤委员会指导的诊疗中兼具应用前景与局限,相关讨论提出以患者为中心的精准肿瘤学框架。该框架的构建聚焦患者报告结局在精准肿瘤学决策中的应用边界。

正文

Acknowledgements

We gratefully acknowledge the fruitful discussions and expert advice provided by all members of the PM4Onco consortium. In particular, we extend our special thanks to Dr. Brita Sedlmayr and Dr. Martin Eichler for their invaluable insights and contributions to the development of this work. This work was supported by the German Federal Ministry of Research, Technology, and Space (BMFTR) under the projects PM4Onco (PM4Onco - 01ZZ2322A, 01ZZ2322I, and 01ZZ2322R), MiHUBx (01ZZ2101A), PCOR-MII (01ZZ2321), and MTB-Alliance (01KD2403). Open Access funding enabled and organized by Projekt DEAL. We gratefully acknowledge support from the SLUB/TU Dresden Open Access Publication Fund. The funder had no role in the conceptualization, writing, or decision to submit this manuscript. Declaration of generative AI and AI-assisted technologies: For the preparation and revision of this article, the authors used ChatGPT (OpenAI) for language editing and stylistic revision. All scientific arguments, interpretations, conclusions, and final manuscript content were reviewed, verified, and approved by the authors. After using this tool, the authors take full responsibility for the published work.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Author information

Author notes

  1. These authors contributed equally: L. Gräßel, S. Yacob.

Authors and Affiliations

  1. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany

    L. Gräßel, S. Yacob & AL Illert

  2. Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

    L. Gräßel

  3. Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    C. Strantz

  4. Institute for Medical Informatics and Biometry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany

    E. Prochaska, S. Bäcker & M. Wolfien

  5. Charité - Universitätsmedizin Berlin, Berlin Institute of Health @ Charité, Berlin, Germany

    T. Debertshäuser & F. Prasser

  6. Center for Patient-Centered Outcomes Research, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charité Platz 1, Berlin, Germany

    AA. Rogge

  7. Department of Psychosomatic Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany

    AA. Rogge

  8. Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    P. Unberath

  9. SRH Fürth University of Applied Sciences, Fürth, Germany

    P. Unberath

  10. Data Integration Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Freiburg, Germany

    J. Wehrle

  11. Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

    S. Jäger & M. Boerries

  12. Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany

    U. Lührig

  13. Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI Dresden/Leipzig), Dresden, Saxony, Germany

    M. Wolfien

Authors

  1. L. Gräßel
  2. S. Yacob
  3. C. Strantz
  4. E. Prochaska
  5. T. Debertshäuser
  6. AA. Rogge
  7. S. Bäcker
  8. F. Prasser
  9. P. Unberath
  10. J. Wehrle
  11. S. Jäger
  12. M. Boerries
  13. AL Illert
  14. U. Lührig
  15. M. Wolfien

Corresponding author

Correspondence to M. Wolfien.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gräßel, L., Yacob, S., Strantz, C. et al. The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology. npj Precis. Onc. (2026). https://doi.org/10.1038/s41698-026-01719-0

Download citation

  • Received: 15 August 2025

  • Accepted: 12 September 2026

  • Published: 29 October 2026

  • DOI: https://doi.org/10.1038/s41698-026-01719-0

来源:Nature 健康护理主题 · nature.com